HistoSonics will use GE Healthcare’s LOGIQ E10 Series ultrasound imaging platform to power its sonic beam liver therapy, according to a May 23 press release.
GE Healthcare’s imaging platform will provide HistoSonics liver therapy with continuous visualization for key and unique elements of the histotripsy therapy procedure, including planning, monitoring and immediate post-treatment verification.
“We are very excited to formalize our imaging partnership with GE Healthcare, which is a key part of bringing our transformative therapy platform, and an entirely new treatment option, to the clinic and to patients,” said Josh Stopek HistoSonics vice president of research and development. “We’ve developed a very collaborative relationship with GE Healthcare and look forward to expanding our efforts to realize the full potential of histotripsy across clinical applications, specialties, and care settings.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
